Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Soppa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Biology : CB|June 17, 2015
DYRK protein kinasesUlf Soppa, Walter Becker
CNS & Neurological Disorders Drug Targets|October 25, 2013
DYRK1A: a potential drug target for multiple Down syndrome neuropathologiesWalter Becker, Ulf Soppa, Francisco J Tejedor
Cell Communication and Signaling : CCS|January 30, 2015
Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK)Jan van der Laden, Ulf Soppa, Walter Becker
Plos One|July 5, 2013
NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effectGeorgios C Stefos, Ulf Soppa, Mara Dierssen, et al.
The FEBS Journal|October 3, 2009
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formationNora Göckler, Guillermo Jofre, Chrisovalantis Papadopoulos, et al.
Cell Cycle (Georgetown, Tex.)|May 9, 2014
The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiationUlf Soppa, Julian Schumacher, Victoria Florencio Ortiz, et al.
Redox Biology|April 28, 2017
Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's diseaseAthanassios Fragoulis, Stephanie Siegl, Markus Fendt, et al.
Clinical and Experimental Rheumatology|November 17, 2023
The impact of C-reactive protein levels on the effectiveness of upadacitinib in patients with rheumatoid arthritis: a 12-month prospective, non-interventional German studyTorsten Witte, Uta Kiltz, Florian Haas, et al.
Arthritis Research & Therapy|October 18, 2012
Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytesAthanassios Fragoulis, Jendrik Laufs, Susanna Müller, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Biology : CB|June 17, 2015
DYRK protein kinasesUlf Soppa, Walter Becker
CNS & Neurological Disorders Drug Targets|October 25, 2013
DYRK1A: a potential drug target for multiple Down syndrome neuropathologiesWalter Becker, Ulf Soppa, Francisco J Tejedor
Cell Communication and Signaling : CCS|January 30, 2015
Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK)Jan van der Laden, Ulf Soppa, Walter Becker
Plos One|July 5, 2013
NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effectGeorgios C Stefos, Ulf Soppa, Mara Dierssen, et al.
The FEBS Journal|October 3, 2009
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formationNora Göckler, Guillermo Jofre, Chrisovalantis Papadopoulos, et al.
Cell Cycle (Georgetown, Tex.)|May 9, 2014
The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiationUlf Soppa, Julian Schumacher, Victoria Florencio Ortiz, et al.
Redox Biology|April 28, 2017
Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's diseaseAthanassios Fragoulis, Stephanie Siegl, Markus Fendt, et al.
Clinical and Experimental Rheumatology|November 17, 2023
The impact of C-reactive protein levels on the effectiveness of upadacitinib in patients with rheumatoid arthritis: a 12-month prospective, non-interventional German studyTorsten Witte, Uta Kiltz, Florian Haas, et al.
Arthritis Research & Therapy|October 18, 2012
Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytesAthanassios Fragoulis, Jendrik Laufs, Susanna Müller, et al.
Pageof 1